speb/financial-data huggingface dataset:
Financial scorecard for ATS (Industrials — Specialty Industrial Machinery, Canada)
Report date: 2026-03-31 (annual)
Stock price: 26.42
Market cap: 2562928640 (USD: 2562928640)
P/E ratio: 54.230769230769226
P/B ratio: 2.1368785102744767
Debt to equity: 0.8187000000000001
Current ratio: 1.64
Interest coverage ratio: 2.207271099617049
Return on net tangible assets (%): -62.23526738838092
Buffett classification: The Great
Rule of 40 score: 33.06137105751979
Altman Z-score: 1.4424092068247039 (Distress Zone)
Piotroski F-score: 8 (Strong)
Magic formula: return on capital % 2.1585243339782707, earnings yield % 0.44682659537755526, rank 2354
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 2.352609979842353
Total shareholder yield (%): 2.352609979842353 (Low Return)
Momentum (%): 1m -5.575411007862755, 3m -20.03631961259079, 6m -10.98382749326145, 12m -16.52448657187993, composite -14.205241241708512 (Moderate Downtrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 8, short score 4, recommendation: Long
Revenue growth 1y (%): 33.84595518742468
Revenue deceleration: no
Revenue growth consistency score: 8.53525966849169
Accrual ratio: -0.0315199864807887
FCF conversion rate: -7.6978578081341205
Beneish M-score: -2.5908001797471734 (Likely Safe)
ROE (%): -0.897964416330862
Net margin (%): -2.1556599290860827
Asset turnover: 0.16810996980101717
Equity multiplier (leverage): 2.4779093147042976
ROE archetype: Low Return
P/E z-score: 4.037792539140112
FCF z-score: 3.33079109406834
Treasury beta 1y: -0.001883940144597118 (R-squared: 0.0004105670062531258)
Insider 90-day net shares: 14758 (net value USD: 448744.00)
ROIC (%): 5.475335844370782 (pretax: 7.571951418418663)
Incremental ROIC 3y (%): -7.12672563755405 (pretax: -5.5863770379084725)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 70.71290944123314, P/B 47.20616570327553, ROIC 57.41811175337187, revenue growth 1y 6.358381502890173, 6m momentum 62.813102119460495
Sector percentiles: P/E 64.08090117767537, 6m momentum 58.166922683051716
Industry median P/E: 0.34832165205981025; industry median ROIC: 8.620128805291433
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.09696608612822438
Base cash flow: 145830215.82733813
DCF price per share: base 15.119584037427094, conservative 11.2834062151264, aggressive 19.928443262600993
Financial scorecard for AVO (Consumer Defensive — Food Distribution, United States)
Report date: 2026-04-30 (quarterly)
Stock price: 12.42
Market cap: 1096931968 (USD: 1096931968)
P/E ratio: 43.3125
P/B ratio: 2.0014920291366907
Debt to equity: 0.35600000000000004
Current ratio: 1.91
Interest coverage ratio: -0.3157894736842105
Return on net tangible assets (%): -2.1327893175074184
Buffett classification: The Gruesome
Analyst consensus upside (%): 19.04761904761905
Rule of 40 score: -6.035394770838922
Altman Z-score: 2.5640068085235113 (Grey Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 10.558704453441296, earnings yield % 4.959562586783218, rank 2907
Dividend yield (%): 0
Buyback yield (%): 0.200559384189631
Debt paydown yield (%): -1.6318240804519977
Total shareholder yield (%): -1.4312646962623667 (Minimal or Negative)
Momentum (%): 1m 1.9704433497536964, 3m -10.195227765726681, 6m -7.726597325408624, 12m 2.1381578947368403, composite -5.919117135641593 (Flat)
Lynch category: Speculative (confidence: Low)
Screener: long score 3, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -23.507757033920583
Net income growth 1y (%): -332.258064516129
Revenue deceleration: no
Revenue growth consistency score: 4.858539581531252
Accrual ratio: 0.02173587915648836
FCF conversion rate: 4.027777777777778
Beneish M-score: -1.9576641233046854 (Likely Safe)
ROE (%): -1.1691158561337989
Net margin (%): -2.4750773461670676
Asset turnover: 0.2900443691111222
Equity multiplier (leverage): 1.6285621498741576
ROE archetype: Low Return
P/E z-score: 3.264659447080376
FCF z-score: 3.264659447080374
Treasury beta 1y: -0.0020551885037996672 (R-squared: 0.0006067205153195749)
Insider 90-day net shares: 3549301 (net value USD: 44691097.00)
ROIC (%): 5.642741749365336 (pretax: 8.624338624338625)
Incremental ROIC 3y (%): 46.52842884915528 (pretax: 74.71751412429379)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 64.7887323943662, P/B 50.70422535211267, ROIC 45.07042253521127, revenue growth 1y 43.66197183098591, 6m momentum 52.112676056338024
Sector percentiles: P/E 59.88414192614048, 6m momentum 45.981173062997826
Industry median P/E: 0.7382173578452391; industry median ROIC: 6.126309823527797
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.06672046891985611
Base cash flow: 23800000
DCF price per share: base 10.640564410681169, conservative 5.948332473587446, aggressive 18.601753800766485
Financial scorecard for AVTR (Healthcare — Medical Instruments & Supplies, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 11.44
Market cap: 7810721280 (USD: 7810721280)
P/E ratio: 30.90532535612009
P/B ratio: 0.9577902466906436
Debt to equity: 0.6829000000000001
Current ratio: 1.76
Interest coverage ratio: 2.3193473193473193
Return on net tangible assets (%): -4.6626863246821815
Buffett classification: The Good
Analyst consensus upside (%): 33.16326530612245
Rule of 40 score: -3.891388813567971
Altman Z-score: 1.2479556132047958 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 5.517968056787933, earnings yield % 0.8768279474559998, rank 1340
Dividend yield (%): 0
Buyback yield (%): 0.04609049370661963
Debt paydown yield (%): 1.664378939405709
Total shareholder yield (%): 1.7104694331123285 (Low Return)
Momentum (%): 1m 18.059855521155832, 3m 44.81012658227847, 6m -3.0508474576271287, 12m -18.344039971448968, composite 3.6413871172106886 (Strong Downtrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 4, short score 4, recommendation: Neutral
Revenue growth 1y (%): 0
Net income growth 1y (%): -32.86821705426357
Revenue deceleration: no
Accrual ratio: 0.0015432032978510255
FCF conversion rate: 0.581986143187067
Beneish M-score: -2.4451284990459157 (Likely Safe)
ROE (%): 0.7764239669347391
Net margin (%): 2.7380801821171112
Asset turnover: 0.13482992791279622
Equity multiplier (leverage): 2.103131696208433
ROE archetype: Low Return
FCF z-score: 5.17838268003102
Treasury beta 1y: -0.005551575550753421 (R-squared: 0.0021043238449289757)
Insider 90-day net shares: 310000 (net value USD: 2685950.00)
ROIC (%): 4.69807236029259 (pretax: 5.94692703834505)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 40.49079754601227, P/B 15.950920245398773, ROIC 46.62576687116564, revenue growth 1y 48.466257668711656, 6m momentum 38.65030674846626
Sector percentiles: P/E 28.04441260744986, 6m momentum 32.91547277936962
Industry median P/E: 15.690276110444179; industry median ROIC: 5.717819487534456
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07693912339823832
Base cash flow: -248800000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AWFIS.NS (Industrials — Rental & Leasing Services, India)
Report date: 2026-03-31 (annual)
Stock price: 2.8060487200660615
Market cap: 19454451712 (USD: 206172654.8537516)
Debt to equity: 2.7173000000000003
Current ratio: 0.68
Interest coverage ratio: 0.890531130713024
Return on net tangible assets (%): 44.91363638850041
Buffett classification: The Gruesome
Rule of 40 score: 38.33436986781083
Altman Z-score: 0.5647210368047286 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 3.6409747633527467, earnings yield % 0.016061440174831198, rank 2511
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -13.886920143192716, 3m -24.406811402811854, 6m , 12m , composite -24.406811402811854 ()
Lynch category: Slow Grower (confidence: Low)
Screener: long score 2, short score 6, recommendation: Neutral
Revenue growth 1y (%): 12.119760270386282
Net income growth 1y (%): -5.362838014199777
Revenue CAGR 3y (%): 33.5708057585719
FCF CAGR 3y (%): 114.78387300769808
Revenue deceleration: yes
Revenue growth consistency score: 20.8583976397018
Beneish M-score: -0.5052365149948738 (Strong Manipulation Signal)
ROE (%): 4.208201721438332
Net margin (%): 5.6682531013497695
Asset turnover: 0.14093380189396634
Equity multiplier (leverage): 5.267834807084866
ROE archetype: Low Return
P/E z-score: 0.5837208168028513
FCF z-score: 0.5837208168028508
Treasury beta 1y: 0.0013280966573598065 (R-squared: 0.0007977238616423802)
Insider 90-day net shares: -5350208 (net value USD: -44522825.00)
ROIC (%): 9.751066471735312 (pretax: 9.94346468955934)
Incremental ROIC 3y (%): 16.61137630693864 (pretax: 16.730961663163118)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B , ROIC 18.269230769230766, revenue growth 1y 18.269230769230766, 6m momentum 
Industry median P/E: 1.3202365863962822; industry median ROIC: 4.993191103041307
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.10424257562348434
Base cash flow: 26104599.40652819
DCF price per share: base 10.02082125975372, conservative 5.120270255574455, aggressive 18.635466836995434
Financial scorecard for AWJ.AX (Basic Materials — Gold, Australia)
Report date: 2025-12-31 (annual)
Stock price: 0.1527777777777778
Market cap: 40225124 (USD: 26996727.516778525)
P/E ratio: 6.263982102908278
P/B ratio: 1.7611114140078903
Debt to equity: 0
Current ratio: 5.12
Return on net tangible assets (%): -6.646436120195497
Buffett classification: The Gruesome
Analyst consensus upside (%): 288.4642857142857
Rule of 40 score: -28.562728070444916
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 1.0076786836008262
Total shareholder yield (%): 1.0076786836008262 (Low Return)
Momentum (%): 1m -3.683574879227052, 3m -33.15972222222222, 6m -28.046594982078854, 12m 28.163580246913593, composite -9.380394368228067 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 6, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.33512132049331905
FCF conversion rate: -0.7753520966046868
Beneish M-score: -2.0004058025792975 (Likely Safe)
ROE (%): 22.312916317729616
Net margin (%): 57.83294051747896
Asset turnover: 0.32639409020872256
Equity multiplier (leverage): 1.18205796956556
ROE archetype: High-Margin Compounder
P/E z-score: 3.501945999199879
Treasury beta 1y: 0.01563593898465288 (R-squared: 0.006788742268143853)
Insider 90-day net shares: 112500 (net value USD: 18585.00)
ROIC (%): 20.932504696307127 (pretax: 21.309132849744476)
Incremental ROIC 3y (%): 40.49366159099638 (pretax: 42.80667817713726)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 10.623229461756374, P/B 18.413597733711047, ROIC 8.923512747875353, revenue growth 1y , 6m momentum 39.6600566572238
Sector percentiles: P/E 23.070516379789005, 6m momentum 52.831760133259294
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.07605
Base cash flow: -1326883.2214765106
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BAJEL.NS (Utilities — Utilities - Regulated Electric, India)
Report date: 2026-03-31 (annual)
Stock price: 1.846614368290669
Market cap: 20698181632 (USD: 219353344.97668505)
Debt to equity: 0.4907
Current ratio: 1.2
Interest coverage ratio: 1.408643635681367
Return on net tangible assets (%): 0.8403290526313254
Buffett classification: The Good
Rule of 40 score: -3.298103367023563
Altman Z-score: 1.3140534372055506 (Distress Zone)
Piotroski F-score: 8 (Strong)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -12.717507288123414, 3m -4.282397995244075, 6m , 12m , composite -4.282397995244075 ()
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 2, short score 6, recommendation: Neutral
Revenue growth 1y (%): 14.244474563619637
Net income growth 1y (%): 165.80039627958425
Revenue deceleration: no
Revenue growth consistency score: 19.795707264471186
Beneish M-score: 1.0296596970680907 (Strong Manipulation Signal)
ROE (%): 1.891489940599494
Net margin (%): 1.420759800340857
Asset turnover: 0.3920701359368913
Equity multiplier (leverage): 3.3956241387087265
ROE archetype: Low Return
P/E z-score: 0.6282754432171114
Treasury beta 1y: 0.0005888690130498383 (R-squared: 0.00018854011912765187)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 6.111216415280593 (pretax: 8.191628590326697)
Incremental ROIC 3y (%): 17.57787766768765 (pretax: 23.35548919826158)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B , ROIC 32.22222222222222, revenue growth 1y 18.88888888888889, 6m momentum 
Industry median P/E: 17.96397344673207; industry median ROIC: 5.461095094053626
Sector median P/E: 8.380462724935732; sector median ROIC: 4.834251840514727
WACC: 0.09810800941216345
Base cash flow: 665748.1983891479
DCF price per share: base 0, conservative 0, aggressive 0.042483692294200986
Financial scorecard for BEX.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.056737588652482275
Market cap: 20833306 (USD: 14987989.928057555)
P/B ratio: 1.3354042534955282
Debt to equity: 0
Current ratio: 14.18
Return on net tangible assets (%): -7.138705065800872
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 82.54887965388025 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.7092198581560359, 3m 29.550827423167874, 6m -21.702127659574476, 12m 28.605200945626503, composite 11.84941009334178 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.05481899829194238
FCF conversion rate: 0.02930142446209856
Beneish M-score: -2.4252895180044756 (Likely Safe)
ROE (%): -5.741094472760421
Asset turnover: 0
Equity multiplier (leverage): 1.016595049230623
ROE archetype: Low Return
Treasury beta 1y: -0.029172214491356655 (R-squared: 0.010557327108135214)
Insider 90-day net shares: 57955358 (net value USD: 2962221.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 20.31640299750208, ROIC , revenue growth 1y , 6m momentum 35.13738551207327
Sector percentiles: P/E , 6m momentum 45.91893392559689
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.15
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BFAM (Consumer Cyclical — Personal Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 75.77
Market cap: 3986007552 (USD: 3986007552)
P/E ratio: 24.737951807228914
P/B ratio: 3.771362671848677
Debt to equity: 1.6352000000000002
Current ratio: 0.46
Interest coverage ratio: 5.402512061221095
Return on net tangible assets (%): -4.271939600604637
Buffett classification: The Good
Analyst consensus upside (%): 10.79995129672471
Rule of 40 score: 8.330074306231579
Altman Z-score: 1.3572957028268624 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 8.857168962474754, earnings yield % 1.134635362138111, rank 804
Dividend yield (%): 0
Buyback yield (%): 5.639628050559198
Debt paydown yield (%): -2.8378019490516007
Total shareholder yield (%): 2.801826101507597 (Low Return)
Momentum (%): 1m 11.557714958775021, 3m -6.479881510738089, 6m -18.90185165364445, 12m -33.112641242937855, composite -21.80803534857949 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 3, short score 4, recommendation: Neutral
Revenue growth 1y (%): 7.016244269578853
Net income growth 1y (%): -10.357696654314175
Revenue deceleration: no
Accrual ratio: -0.013927772786607758
FCF conversion rate: 2.568312419373754
Beneish M-score: -2.8817684804737294 (Likely Safe)
ROE (%): 2.7451979358699936
Net margin (%): 4.788956252404447
Asset turnover: 0.18544205095385013
Equity multiplier (leverage): 3.0911819731894896
ROE archetype: Low Return
P/E z-score: 4.969110674166097
FCF z-score: 4.969110674166098
Treasury beta 1y: 0.002029600774047621 (R-squared: 0.00037497015826169864)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 7.647309983560656 (pretax: 10.688200334166542)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 62.0253164556962, P/B 58.22784810126582, ROIC 30.37974683544304, revenue growth 1y 13.924050632911392, 6m momentum 62.0253164556962
Sector percentiles: P/E 56.05006954102921, 6m momentum 64.36022253129346
Industry median P/E: 0.17977747862805335; industry median ROIC: 6.5091735771840575
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.08733441077810816
Base cash flow: 195201000
DCF price per share: base 107.73539262753526, conservative 49.03414454670589, aggressive 211.8821686741048
Financial scorecard for BFRG (Healthcare — Health Information Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 0.59
Market cap: 10865409 (USD: 10865409)
P/B ratio: 6.374320833446735
Debt to equity: 0.0274
Current ratio: 8.15
Interest coverage ratio: -1644.223014256619
Return on net tangible assets (%): -32.592554091222645
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 3.7561442985706233 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -7.812500000000007, 3m -27.160493827160504, 6m -18.055555555555557, 12m -62.65822784810127, composite -34.90324008959734 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 13, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.024182200192782884
FCF conversion rate: 1.063350157328732
Beneish M-score: -2.462679250928536 (Likely Safe)
ROE (%): -45.36903826219686
Asset turnover: 0
Equity multiplier (leverage): 1.1885335862123956
ROE archetype: Low Return
Treasury beta 1y: -0.0021668357540087224 (R-squared: 3.7570211143008935e-05)
Insider 90-day net shares: -50000 (net value USD: -76536.00)
Incremental ROIC 3y (%): -219.60282583319568 (pretax: -277.9782605483489)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 48.94736842105264, ROIC , revenue growth 1y , 6m momentum 41.578947368421055
Sector percentiles: P/E , 6m momentum 48.24498567335244
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -6496343
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BMC.AX (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2025-06-30 (annual)
Stock price: 1.8680555555555556
Market cap: 738781120 (USD: 539256291.9708029)
Debt to equity: 7.563400000000001
Current ratio: 36.78
Interest coverage ratio: -12.8248350329934
Return on net tangible assets (%): -66.88778330569376
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -4.623924100156489, 3m -7.259653270291564, 6m -14.502786485545109, 12m , composite -10.881219877918337 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.15552047852454934
FCF conversion rate: 0.6199756394640681
Beneish M-score: -2.48 (Likely Safe)
ROE (%): -123.7750640735715
Equity multiplier (leverage): 3.0245238454193673
ROE archetype: Low Return
Treasury beta 1y: 0.003585274968991202 (R-squared: 0.0006887613017500749)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 29.558701082431305
Sector percentiles: P/E , 6m momentum 38.811771238201
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.10318728163050953
Base cash flow: -19430656.93430657
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BMH.AX (Basic Materials — Building Materials, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.006944444444444445
Market cap: 1629751 (USD: 1065196.7320261437)
Current ratio: 0.59
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -2.77777777777778, 6m 1.3888888888888886, 12m 4.861111111111119, composite 0.9163473818646265 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Revenue growth consistency score: 368.597720978616
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.00881528833887644 (R-squared: 0.00015511338691675004)
Insider 90-day net shares: 2000000 (net value USD: 13000.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 18.253968253968253
Sector percentiles: P/E , 6m momentum 20.960577456968352
Industry median P/E: 0.40903784698558243; industry median ROIC: 6.160009846970938
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BRM.V (Industrials — Pollution & Treatment Controls, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 2.141843971631206
Market cap: 49028904 (USD: 35272592.8057554)
P/E ratio: 6.554756195043964
P/B ratio: 2.6108118442973067
Debt to equity: 0.1732
Current ratio: 2.02
Interest coverage ratio: 5.201412731468453
Return on net tangible assets (%): 0.13770720799992264
Buffett classification: The Gruesome
Analyst consensus upside (%): 97.76422764227641
Rule of 40 score: -81.11448823462094
Altman Z-score: 2.867154651976121 (Grey Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.45537757694215614
Total shareholder yield (%): 0.45537757694215614 (Low Return)
Momentum (%): 1m -2.5186397526823048, 3m -5.344314802104759, 6m 25.24341868012983, 12m 30.623668225042156, composite 17.96590479169606 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 3, short score 6, recommendation: Neutral
Revenue growth 1y (%): 48.25495296304814
Net income growth 1y (%): 457.36215677119264
Revenue deceleration: no
Accrual ratio: 0.04883207086750043
FCF conversion rate: -6.956278806420852
Beneish M-score: -1.7054180327587878 (Possible Manipulation)
ROE (%): 1.3228636996809937
Net margin (%): 2.953607975962034
Asset turnover: 0.20779844661188274
Equity multiplier (leverage): 2.155360653475828
ROE archetype: Low Return
P/E z-score: 4.598588146075875
FCF z-score: 3.8639157775092476
Treasury beta 1y: 0.006082088589760552 (R-squared: 0.003389206179974637)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 80.0276187068539 (pretax: 105.14869032947513)
Incremental ROIC 3y (%): 444.51333470862335 (pretax: 543.1668419689372)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 21.794871794871796, P/B 38.46153846153847, ROIC 1.282051282051282, revenue growth 1y 10.256410256410255, 6m momentum 7.6923076923076925
Sector percentiles: P/E 45.69892473118279, 6m momentum 14.464925755248338
Industry median P/E: 0.3692094247203502; industry median ROIC: -1.8898100942920708
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.0929689142983606
Base cash flow: 3591113.138686131
DCF price per share: base 7.914164424033878, conservative 4.757287493043512, aggressive 13.47112276537338
Financial scorecard for BTSG (Healthcare — Health Information Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 72.91
Market cap: 14309201920 (USD: 14309201920)
P/E ratio: 55.33766233766234
P/B ratio: 4.202522917222182
Debt to equity: 1.3568
Current ratio: 1.74
Interest coverage ratio: 3.1451249514437394
Return on net tangible assets (%): -15.24276409307492
Buffett classification: The Great
Analyst consensus upside (%): 79.04247829148089
Rule of 40 score: 4.481088206824922
Altman Z-score: 2.90247788222137 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 8.010577082899108, earnings yield % 0.7222384959644418, rank 1151
Dividend yield (%): 0
Buyback yield (%): 0.41931059702314966
Debt paydown yield (%): 0.05265143396620683
Total shareholder yield (%): 0.47196203098935646 (Low Return)
Momentum (%): 1m 7.839077059606563, 3m 51.39119601328904, 6m 83.93037336024217, 12m 252.90416263310743, composite 120.85743180472984 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 5, short score 6, recommendation: Neutral
Revenue growth 1y (%): 25.557992709847266
Net income growth 1y (%): 403.57795680725746
Revenue deceleration: no
Accrual ratio: 0.0075028758674626035
FCF conversion rate: 0.6815960528880733
Beneish M-score: -2.4406877043161646 (Likely Safe)
ROE (%): 7.675802881076832
Net margin (%): 4.116726222085214
Asset turnover: 0.572396978606714
Equity multiplier (leverage): 3.257425522907525
ROE archetype: Standard Business
P/E z-score: 1.8449959572584549
FCF z-score: 3.2755125472746585
Treasury beta 1y: 0.020007271156696572 (R-squared: 0.047602214851200315)
Insider 90-day net shares: -14999771 (net value USD: -876879624.00)
ROIC (%): 4.978824652850404 (pretax: 6.553533068426634)
Incremental ROIC 3y (%): 75.62814898476611 (pretax: 115.34369530938642)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 32.10526315789474, P/B 43.684210526315795, ROIC 28.947368421052634, revenue growth 1y 12.631578947368421, 6m momentum 1.5789473684210527
Sector percentiles: P/E 31.626074498567334, 6m momentum 2.9727793696275073
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.11850901275976132
Base cash flow: 259459000
DCF price per share: base 21.235580233749296, conservative 7.257403189929202, aggressive 45.30982967971048
Financial scorecard for BULL (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 7.49
Market cap: 3983321600 (USD: 3983321600)
P/B ratio: 2.111725606514706
Debt to equity: 0.0751
Current ratio: 1.28
Return on net tangible assets (%): -2.3285725379958797
Buffett classification: The Gruesome
Analyst consensus upside (%): 156.875
Rule of 40 score: -3.1905832839413346
Altman Z-score: 0.394444165456842 (Distress Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 5.80261043911563, earnings yield % 2.7863251933211655, rank 4237
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.02546465241470837
Total shareholder yield (%): 0.02546465241470837 (Low Return)
Momentum (%): 1m 11.624441132637859, 3m 8.550724637681157, 6m -4.46428571428571, 12m -53.44934742075823, composite -18.070213335872534 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 15, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 36.26105771604533
Net income growth 1y (%): -266.00221904541314
Revenue deceleration: no
Beneish M-score: -2.464721617081694 (Likely Safe)
ROE (%): -2.1352243255752197
Net margin (%): -13.582817159440033
Asset turnover: 0.04211761244394136
Equity multiplier (leverage): 3.732414860525852
ROE archetype: Low Return
P/E z-score: 4.129560393222557
FCF z-score: 4.129560393222556
Treasury beta 1y: 0.006618314120154775 (R-squared: 0.001964931717219479)
Insider 90-day net shares: -75000 (net value USD: -466830.00)
ROIC (%): 14.155408347129026 (pretax: 21.777551303275423)
Incremental ROIC 3y (%): -0.3053718923940707 (pretax: -0.4698029113754933)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 31.536388140161726, ROIC 28.84097035040431, revenue growth 1y 9.568733153638814, 6m momentum 29.110512129380055
Sector percentiles: P/E , 6m momentum 37.33733733733734
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.07646688316598949
Base cash flow: 23117916
DCF price per share: base 4.154375207694402, conservative 3.0314252183956154, aggressive 6.238738106282498
Financial scorecard for BURL (Consumer Cyclical — Apparel Retail, United States)
Report date: 2026-04-30 (quarterly)
Stock price: 349.97
Market cap: 22027884544 (USD: 22027884544)
P/E ratio: 31.969030969030968
P/B ratio: 10.967274998440024
Debt to equity: 3.1973000000000003
Current ratio: 1.16
Interest coverage ratio: 10.165262200666868
Return on net tangible assets (%): -4.531799165067679
Buffett classification: The Gruesome
Analyst consensus upside (%): 14.705790444048624
Rule of 40 score: -30.944162400702847
Altman Z-score: 2.373306355301593 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 2.3119525475862286, earnings yield % 0.623489619859115, rank 2183
Dividend yield (%): 0
Buyback yield (%): 0.6094956587039573
Debt paydown yield (%): 0.6064585990232435
Total shareholder yield (%): 1.215954257727201 (Low Return)
Momentum (%): 1m 3.605790579946122, 3m 5.485728064623096, 6m 17.455363135991426, 12m 26.434248554913296, composite 14.991683579395593 (Moderate Uptrend)
Lynch category: Stalwart (confidence: Medium)
Screener: long score 1, short score 7, recommendation: Neutral
Revenue growth 1y (%): 14.075007388119909
Net income growth 1y (%): 13.796078664722856
Revenue deceleration: no
Revenue growth consistency score: 1.9619123952455948
Accrual ratio: 0.034822870606187946
FCF conversion rate: -1.9887401519905181
Beneish M-score: -2.25519459686052 (Likely Safe)
ROE (%): 6.297995568394319
Net margin (%): 4.016998656729428
Asset turnover: 0.29005123868496596
Equity multiplier (leverage): 5.4053763818579705
ROE archetype: Standard Business
P/E z-score: 4.734640797760528
FCF z-score: 3.959599319814191
Treasury beta 1y: -0.0028281804415632708 (R-squared: 0.0010704207920410583)
Insider 90-day net shares: -37998 (net value USD: -12786844.00)
ROIC (%): 9.600475496434651 (pretax: 12.841239592691103)
Incremental ROIC 3y (%): 17.641782092124572 (pretax: 23.615787428150632)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 60.17699115044248, P/B 68.14159292035397, ROIC 41.5929203539823, revenue growth 1y 11.504424778761061, 6m momentum 13.274336283185843
Sector percentiles: P/E 58.692628650904034, 6m momentum 14.464534075104313
Industry median P/E: 1.3496143958868894; industry median ROIC: 7.604854611108472
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.09834001448222618
Base cash flow: -27026000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BUS.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.05555555555555556
Market cap: 5451264 (USD: 3562917.6470588236)
P/B ratio: 1.1651963000753591
Debt to equity: 0
Current ratio: 15.94
Return on net tangible assets (%): -43.89732509053078
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 0 (Weak)
Dividend yield (%): 0
Buyback yield (%): 3.881448412698413
Total shareholder yield (%): 3.881448412698413 (Low Return)
Momentum (%): 1m 0.6944444444444402, 3m -2.77777777777778, 6m -32.407407407407405, 12m -16.11111111111111, composite -17.29161345253299 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.0405252348324539
FCF conversion rate: 1.1328533921470278
Beneish M-score: -2.9143636191824993 (Likely Safe)
Equity multiplier (leverage): 1.0204104395494469
ROE archetype: Standard Business
Treasury beta 1y: 0.032669626967065594 (R-squared: 0.018753126424909918)
Insider 90-day net shares: 456060 (net value USD: 31478.00)
ROIC (%): -50.65092475058105 (pretax: -64.11509462098867)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 18.401332223147378, ROIC 44.296419650291426, revenue growth 1y , 6m momentum 44.12989175686928
Sector percentiles: P/E , 6m momentum 56.19100499722376
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.07
Base cash flow: -1720878.431372549
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CAI (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 15.52
Market cap: 4387204608 (USD: 4387204608)
P/E ratio: 148.73553135777766
P/B ratio: 8.516286418642268
Debt to equity: 0.7261
Current ratio: 7.05
Interest coverage ratio: 0.4123663049418378
Return on net tangible assets (%): -1.007931780418221
Buffett classification: The Gruesome
Analyst consensus upside (%): 51.006711409395976
Rule of 40 score: -23.109983899854768
Altman Z-score: 2.6561140382749064 (Grey Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 0.5542770734758168, earnings yield % 0.1322251888550193, rank 2785
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.07458051976954888
Total shareholder yield (%): -0.07458051976954888 (Minimal or Negative)
Momentum (%): 1m -14.490358126721759, 3m -23.168316831683168, 6m -37.92, 12m -47.371990505256015, composite -33.18067665159192 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 6, recommendation: Neutral
Revenue growth 1y (%): 78.78178885994294
Revenue deceleration: no
Accrual ratio: -0.020142907653719257
FCF conversion rate: -44.1843137254902
Beneish M-score: -2.725488790025394 (Likely Safe)
ROE (%): -0.08712014123712308
Net margin (%): -0.23592106358766549
Asset turnover: 0.1889590747758682
Equity multiplier (leverage): 1.9542679046837326
ROE archetype: Low Return
FCF z-score: 1.3246527968394433
Treasury beta 1y: -0.007617612275422479 (R-squared: 0.0028358645264447598)
Insider 90-day net shares: 31050 (net value USD: 501426.00)
ROIC (%): 17.26508061078169 (pretax: 21.854532418711003)
Incremental ROIC 3y (%): 13.925074085778801 (pretax: 17.62667605794785)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 13.537906137184116, P/B 55.77617328519856, ROIC 4.241877256317689, revenue growth 1y 6.678700361010831, 6m momentum 59.47653429602888
Sector percentiles: P/E 33.703438395415475, 6m momentum 64.21919770773638
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10206545798010548
Base cash flow: -61733000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CALC (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 0.76
Market cap: 12004923 (USD: 12004923)
P/E ratio: 0.42860413685691323
Debt to equity: -6.068840579710145
Current ratio: 1.61
Interest coverage ratio: -17.58934169278997
Return on net tangible assets (%): -451.35869565217394
Buffett classification: The Gruesome
Analyst consensus upside (%): 1844.4444444444446
Rule of 40 score: 0
Altman Z-score: -30.93642107932917 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 24.98974795590109
Total shareholder yield (%): 24.98974795590109 (High Return)
Momentum (%): 1m 26.66666666666667, 3m 31.0344827586207, 6m -85.55133079847909, 12m -79.40379403794037, composite -46.08556181274412 (Strong Downtrend)
Lynch category: Turnaround (confidence: Low)
Screener: long score 1, short score 12, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: 0.8857657657657657
FCF conversion rate: -0.9758842443729904
Beneish M-score: -2.6177085306123486 (Likely Safe)
Asset turnover: 0
ROE archetype: Standard Business
Treasury beta 1y: 0.00037964244456875233 (R-squared: 1.3691896213320072e-06)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 2.3465703971119134, P/B , ROIC , revenue growth 1y , 6m momentum 77.70758122743683
Sector percentiles: P/E 9.742120343839542, 6m momentum 79.22636103151862
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10862011381984672
Base cash flow: -29544000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CBL.AX (Healthcare — Medical Devices, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.04861111111111112
Market cap: 30726918 (USD: 20082952.94117647)
Debt to equity: 0.0308
Current ratio: 2.22
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -21.682098765432084, 3m 13.425925925925943, 6m 1.388888888888896, 12m 83.50694444444447, composite 49.70838654746702 (Strong Uptrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Revenue growth consistency score: 12.411159878251576
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.00026768366223375753 (R-squared: 5.76480923935368e-07)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 19.287833827893174
Sector percentiles: P/E , 6m momentum 26.71919770773639
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05405
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CBNA (Financial Services — Banks - Regional, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 42.25
Market cap: 277105536 (USD: 277105536)
P/E ratio: 10.54380664652568
P/B ratio: 0.6718895113652609
Debt to equity: 0
Return on net tangible assets (%): 3.696354538956397
Buffett classification: The Gruesome
Analyst consensus upside (%): 12.46418338108883
Rule of 40 score: 34.879337498422395
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 12.636630231938156, 3m 20.370370370370367, 6m 26.87687687687689, 12m 56.82999257609502, composite 28.827528344974525 (Strong Uptrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 4, short score 2, recommendation: Neutral
Revenue growth 1y (%): 19.29993136582018
Net income growth 1y (%): 26.128054217941866
Revenue deceleration: no
Accrual ratio: 0.0022795948731464326
FCF conversion rate: 0.40865384615384615
Beneish M-score: -2.134838714935081 (Likely Safe)
ROE (%): 4.110504687672554
Net margin (%): 40.68576688528363
Asset turnover: 0.009474872808472331
Equity multiplier (leverage): 10.662996158026585
ROE archetype: Low Return
P/E z-score: 3.3615038656734275
FCF z-score: 3.3615038656734297
Treasury beta 1y: 0.0023851417852209923 (R-squared: 0.0010471378937633032)
Insider 90-day net shares: -486 (net value USD: -17683.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 48.29192546583851, P/B 23.91304347826087, ROIC , revenue growth 1y 15.062111801242237, 6m momentum 19.565217391304348
Sector percentiles: P/E 33.03155716502845, 6m momentum 7.966890843248836
Industry median P/E: 10.091388400702987; industry median ROIC: 0.8427644093631484
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.1019
Base cash flow: 16595000
DCF price per share: base 338.79504523761705, conservative 269.6878566018966, aggressive 460.7428225472262
Financial scorecard for CDL.L (Basic Materials — Other Industrial Metals & Mining, United Kingdom)
Report date: 2025-12-31 (quarterly)
Stock price: 0
Market cap: 10436746 (USD: 14103710.810810812)
Debt to equity: -0.043687008487913605
Current ratio: 0.38
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.29353202406978113
Total shareholder yield (%): 0.29353202406978113 (Low Return)
Momentum (%): 1m -100, 3m , 6m -100, 12m , composite -100 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 1, short score 4, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.5353767801268967 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.6608864134887559 (R-squared: 0.0028149871020684146)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 80.68276436303081
Sector percentiles: P/E , 6m momentum 83.564686285397
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.08163399100899102
Base cash flow: -3709023.287671233
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CDRO (Consumer Cyclical — Gambling, Luxembourg)
Report date: 2025-12-31 (annual)
Stock price: 9.27
Market cap: 421506144 (USD: 421506144)
P/E ratio: 267.66666666666663
P/B ratio: 10.814513374886753
Debt to equity: 0.1368
Current ratio: 1.37
Return on net tangible assets (%): 6.498283472290339
Buffett classification: The Great
Analyst consensus upside (%): 49.43960149439603
Rule of 40 score: 26.20664670057284
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 27.80308169396259, earnings yield % 1.8007704500651713, rank 2000
Dividend yield (%): 0
Buyback yield (%): 0.6584231706114962
Debt paydown yield (%): 0.23027540969841714
Total shareholder yield (%): 0.8886985803099134 (Low Return)
Momentum (%): 1m -3.235908141962427, 3m 3.3444816053511586, 6m 15.874999999999995, 12m 9.964412811387898, composite 10.953745746663119 (Moderate Uptrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 8, short score 1, recommendation: Long
Revenue deceleration: no
Beneish M-score: -2.4275455114073194 (Likely Safe)
Equity multiplier (leverage): 3.055547660136027
ROE archetype: Standard Business
P/E z-score: 2.7898791710719357
FCF z-score: 2.7898791710719366
Treasury beta 1y: 0.007240475222582118 (R-squared: 0.009865092818391995)
Insider 90-day net shares: -20000 (net value USD: -200536.00)
Incremental ROIC 3y (%): 2519.915022081349 (pretax: 3248.476416861668)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 46.03174603174603, P/B 57.14285714285714, ROIC , revenue growth 1y , 6m momentum 14.285714285714285
Sector percentiles: P/E 64.15159944367177, 6m momentum 15.368567454798331
Industry median P/E: 16.180729951448185; industry median ROIC: 5.072451584604492
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.07080060203581408
Base cash flow: 2182352.941176471
DCF price per share: base 4.359724536162247, conservative 2.9945209846017775, aggressive 6.961187850519228
Financial scorecard for CDXS (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 1.48
Market cap: 134526928 (USD: 134526928)
P/B ratio: 3.4269649861220333
Debt to equity: 1.6862000000000001
Current ratio: 5.36
Interest coverage ratio: -6.234883720930233
Return on net tangible assets (%): -16.33268744941257
Buffett classification: The Gruesome
Analyst consensus upside (%): 303.680981595092
Rule of 40 score: -157.57739646731872
Altman Z-score: -5.209731080158204 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.2267204079766097
Total shareholder yield (%): 0.2267204079766097 (Low Return)
Momentum (%): 1m -34.801762114537446, 3m -43.51145038167939, 6m -11.904761904761903, 12m -54.320987654320994, composite -28.45149463045986 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 102.14768659684475
Revenue deceleration: no
Accrual ratio: 0.033351733792262424
FCF conversion rate: 1.5310202205882353
Beneish M-score: -2.094652718325535 (Likely Safe)
ROE (%): -18.56595885370562
Net margin (%): -57.08289611752361
Asset turnover: 0.11002752852973118
Equity multiplier (leverage): 2.956038096050681
ROE archetype: Low Return
Treasury beta 1y: -0.014352666268121922 (R-squared: 0.005304018767200214)
Insider 90-day net shares: -2605 (net value USD: -6174.00)
ROIC (%): -66.51353013530135 (pretax: -84.19434194341943)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 37.274368231046935, ROIC 21.841155234657037, revenue growth 1y 5.415162454873646, 6m momentum 36.1913357400722
Sector percentiles: P/E , 6m momentum 42.01289398280802
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.14059410354106225
Base cash flow: -43192000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CG1.AX (Basic Materials — Specialty Chemicals, Australia)
Report date: 2024-06-30 (annual)
Stock price: 0.0625
Market cap: 38133072 (USD: 25422048)
P/B ratio: 2.825652340294204
Debt to equity: 2.3178
Current ratio: 0.19
Interest coverage ratio: -2.0615178617434493
Return on net tangible assets (%): -113.09755158734187
Buffett classification: The Gruesome
Rule of 40 score: 10.228020574931676
Altman Z-score: -3.905513654510206 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.5269441706663445
Debt paydown yield (%): -5.707156540083586
Total shareholder yield (%): -5.180212369417242 (Minimal or Negative)
Momentum (%): 1m 51.04166666666667, 3m -2.7777777777777892, 6m 1.3888888888888946, 12m 34.82142857142857, composite -4.04260171501551 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -1.3500437437836799
Revenue CAGR 3y (%): 3.2116628264441838
Revenue deceleration: no
Revenue growth consistency score: 29.139007184295707
Accrual ratio: -0.29714863515785783
FCF conversion rate: -0.21569726127945568
Beneish M-score: -3.0207330772116476 (Likely Safe)
ROE (%): -60.352219100994084
Net margin (%): -53.677382132890905
Asset turnover: 0.45536219781780923
Equity multiplier (leverage): 2.46913560394578
ROE archetype: Low Return
FCF z-score: 4.604634349334684
Treasury beta 1y: 0.0023154473521560756 (R-squared: 0.00012556050745687807)
Insider 90-day net shares: 230000 (net value USD: 6670.00)
ROIC (%): -22.767618089238393 (pretax: -28.819769733213157)
Incremental ROIC 3y (%): 15.04209223954534 (pretax: 19.040623088032063)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 61.86046511627907, ROIC 82.7906976744186, revenue growth 1y 35.116279069767444, 6m momentum 46.27906976744186
Sector percentiles: P/E , 6m momentum 20.544142143253747
Industry median P/E: 0.2375559102197765; industry median ROIC: 5.779832452013451
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: -3862776.0000000005
DCF price per share: base 0, conservative 0, aggressive 0